Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study

Rheumatology

Volumn 41, Issue 11, 2002, Pages 1240-1248

  Karlsson, J ^a   Sjogren L S ^b   Lohmander, L S ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hyaluronan; Intra articular injections; Knee osteoarthritis; Lequesne algofunctional index; VAS measurements; WOMAC index

Indexed keywords

ARTZAL; HYALURONIC ACID; PARACETAMOL;

ADULT; AGED; ARTICLE; BONE PAIN; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MULTICENTER STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT BEARING;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PHARMACEUTICAL PREPARATIONS; PROBABILITY; RANGE OF MOTION, ARTICULAR; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036852329     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rodriguez LAG, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
2. Rashad S, Low F, Revell P, Hemingway A, Rainsford K. Walker F. Effect of non-steroidal anti-inflammatory drugs on course of osteoarthritis [letter]. Lancet 1989; 2:1149.
3. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992;19:1950-4.
4. Weiss C, Balazs EA, St Onge R, Denlinger JL. Clinical studies of the intra-articular injection of Healon® (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin Arthritis Rheum 1981;11(Suppl. 1):143-4.
5. Isdale AH, Hordon LD, Bird HA, Wright V. Intra-articular hyaluronate (Healon®); a dose ranging study in rheumatoid arthritis and osteoarthritis. J Drug Dev 1991; 2:93-9.
6. Bragantini A, Cassini M, DeBastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan®) in osteoarthritis of the knee. Clin Trial J 1987;24:333-40.
7. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987;2:137-41.
8. Balazs EA, Denlinger JL. Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 1993;20(Suppl. 39):3-9.
9. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993;1:97-103.
10. Puhl W, Bernau A, Greiling H et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage 1993;1:233-41.
11. Puhl W, Scharf P. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1997;56:441-6.
12. Creamer P, Sharif M, George E. et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 1994;2:133-40.
13. Dahlberg L, Lohmander S, Ryd L. Intra-articular injections of hyaluronan in patients with cartilage abnormalities and knee pain. Arthritis Rheum 1994; 37:521-8.
14. Maheu E. Hyaluronan in knee osteoarthritis. A review of the clinical trials with Hyalgan. Eur J Rheum Inflamm 1995;15:1:17-24.
15. Adams ME, Atkinson MH, Lussier AJ et al. The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAID) and NSAID alone. Osteoarthritis Cartilage 1995; 3:213-26.
16. Lohmander LS, Dalén N, Englund G et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo-controlled multicenter trial. Ann Rheum Dis 1996;55:424-31.
17. George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998;57:637-40.
18. Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000; 43:1192-203.
19. Ghosh P, Read R, Numata Y, Smith S, Armstrong S, Wilson D. The effects of intra-articular administration of hyaluronan in a model of early osteoarthritis in sheep. VII. Cartilage composition and proteoglycan metabolism. Semin Arthritis Rheum 1993;22(Suppl. 1):31-42.
20. Ghosh P, Read R, Armstrong S, Wilson D, Marshall R, McNeir P. The effects of intra-articular administration of hyaluronan in a model of early osteoarthritis in sheep. I. Gait analysis, radiological and morphological studies. Semin Arthritis Rheum 1993;22(Suppl. 1):18-3.
21. Marshall KW. The current status of hylan therapy for the treatment of osteoarthritis. Today's Ther Trends 1997; 15:99-108.
22. Aviad AD, Houpt JB. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol 1994;21:297-301.
23. Puttick MPE, Wade JP, Chalmers A, Connell, DG, Rango KK. Acute local reactions after intra-articular Hylan for osteoarthritis of the knee. J Rheumatol 1995; 22:1311-4.
24. Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity of osteoarthritis of the hip and knee. Validation-Value in comparison with other assessment tests. Scand J Rheumatol 1987;65(Suppl.):85-9.
25. Ahlbäck S. Osteoarthritis of the knee: a radiographic investigation. Acta Radiol (Stockholm) 1968; 277(Suppl.):7-72.
26. Altman R, Brandt K, Hochberg M et al. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 1996;4:217-43.
27. Bellamy N, Buchanan W, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee. J Rheumatol 1988;15:1833-40.
28. Bellamy N, Buchanan W, Goldsmith CH. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. Orthop Rheumat 1988;1:95-108.
29. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
30. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. Boston: New England Medical Center, The Health Institute, 1993.
31. Ware JE, Kosinski M, Keller SK. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, 1994.
32. Laurent T, Fraser J. Hyaluronan. FASEB J 1992; 6:2397-404.
33. Laurent UBG, Fraser JRE, Engström-Laurent A, Reed RK, Dahl LB, Laurent TC. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 1992;12:130-6.
34. Miller HJ, White J, Norton TH. The value of intra-articular injections in osteoarthritis of the knee. J Bone Joint Surg Br 1958;40:636-43.
35. Brandt KD, Black JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT and the ORTHOVISC Study Group. Efficacy and safety of intra-articular sodium-hyaluronate in knee osteoarthritis. Clin Orthop 2001; 385:130-43.
36. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single center double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994;53:529-34.
37. Wobig M, Bach G, Beks P et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: A comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 1999; 21:1549-62.
38. Allard S, O'Reagan M. Letter to the editor. Clin Ther 2000;22:792-3.